The Impact of Process and Formulation Parameters on the Fabrication of Efavirenz Nanosuspension to Improve Drug Solubility and Dissolution.

Authors:
Rashed M; Dadashzadeh S; Bolourchian N.

Journal:
Iran J Pharm Res

Publication Year: 2022

DOI:
10.5812/ijpr-129409

PMCID:
PMC10024318

PMID:
36942076

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Iran J Pharm Res

Abbreviation: Iran J Pharm Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A Mechanistic Study on the Fluidization and Enhancement Effects of Cineole Toward Stratum Corneum I…
Karami L; Moghimi HR. (2023) - Transparency Score: 3/6
Calcium Dobesilate Ameliorates Cisplatin-induced Hepatotoxicity by Inhibiting Liver Oxidative Stres…
Bazmandegan G; Kamiab Z; Shafiei A and 2 more (2023) - Transparency Score: 3/6
Consumers' Willingness to Pay for Pharmacist Counselling Services and the Factors Affecting It in C…
Soodi O; Hesari E; Hojjatifard R and 1 more (2023) - Transparency Score: 3/6
Dissolving Microneedles Loaded with Gestodene: Fabrication and Characterization In Vitro and In Viv…
Duan X; Ma J; Ning M and 1 more (2023) - Transparency Score: 3/6
Effects of Komouni Formulation (Herbal Product of Persian Medicine) With a Low-Calorie Diet on Card…
Aghabeiglooei Z; Namazi N; Karimi M and 3 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interests: The authors declare no conflict of interest."

Evidence found in paper:

"Funding/Support: This study was financially supported by a grant (No. 28573) from the research deputy of Shahid Beheshti University of Medical Sciences."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025